This website is intended for healthcare professionals who are currently residing and practising in the United Kingdom and Ireland

I am a healthcare professional in the UK / Ireland I am a member of the public
By checking this box, you hereby confirm that you are a healthcare professional and that you reside and practise within the United Kingdom or Ireland
Please confirm that you have read and accepted our Privacy statement and Terms of use

You are now leaving the Gilead, promotional website.

For more information about Fungal Infection in the UK, you are being directed to the page

Continue Cancel

Welcome to the
Gilead Anti-Infectives Forum

View Resources

The Gilead Anti-Infectives Forum is a promotional website intended for healthcare professionals in the UK and Ireland, and has been designed, built, and funded by Gilead Sciences Ltd.

Information about this site

Explore expert insights and stay informed about the latest themes in invasive fungal infections and cystic fibrosis (CF).

Access up-to-date information on AmBisome® (liposomal amphotericin B) for the treatment of systemic fungal infections in adults and children (aged 1 month to 18 years old), and Cayston® (aztreonam lysine for inhalation) for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with CF aged 6 years and older.

Please refer to the AmBisome® summary of product characteristics (SPC) for full information on the use of AmBisome®. AmBisome® SPC (UK & IRE). Available from: and

Please refer to the Cayston® SPC for full information on the use of Cayston®. Cayston® SPC (UK & IRE). Available from: and